Trading Halt: Halt Status Updated at 4:40:00 PM ET: Quotation Resumption: News and Resumption Times
Trading Halt: Halt Status Updated at 4:40:00 PM ET: Quotation Resumption: News and Resumption Times
Clever Leaves Announces Voluntary Delisting and SEC Deregistration
TOCANCIPÁ, Colombia, April 26, 2024 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ:CLVR, CLVRW)) ("Clever Leaves" or the "Company"), a global medicinal cannabis company, today announced that its Board of
Weed Giants Tilray And Curaleaf Ramp Up Presence In Europe, Here's Why
The European cannabis market is one of the most rapidly expanding markets globally. Prohibition Partners revealed in its latest report on cannabis in Europe that the combined market size of all CBD ca
Can Cannabis Treat Severe Forms Of Epilepsy? New Medicine Sparks Hope As Colombia's Weed Industry Goes Global
Clever Leaves Holdings Inc. (NASDAQ:CLVR) (OTC:CLVRW), a prominent global medical cannabis company announced a strategic partnership with the renowned Dutch seed bank, Paradise Seeds to develop and re
Clever Leaves and Paradise Seeds to Develop and Register Genetic Assets in Colombia
TOCANCIPÁ, Colombia, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ:CLVR, CLVRW)) ("Clever Leaves" or the "Company"), a global medicinal cannabis company, announced today that through its
Clever Leaves Granted Australian GMP Certification for Cannabis Products by the Therapeutic Goods Administration (TGA)
Multinational operator has been granted Australian GMP certification by the TGA for the manufacturing of cannabis products. Clever Leaves is the first and only medicinal cannabis company globally that has GMP
Colombia's President Wants Weed Legalized Despite Senate Opposition: Prohibition Increases 'Profits Of Drug Trafficking, Violence'
A measure that seeks to legalize marijuana in Colombia has been put on hold by Senate members on Tuesday. Before that, the measure had advanced through the Chamber of Representatives and a Senate comm
Clever Leaves to Hold Third Quarter 2023 Conference Call on Thursday, November 9, 2023 at 5:00 P.m. ET
TOCANCIPÁ, Colombia, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ:CLVR, CLVRW)) ("Clever Leaves" or the "Company"), a global medicinal cannabis company, will hold a conference call on Thursday,
Clever Leaves Regains Compliance With Nasdaq Minimum Bid Price Requirement
Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) announced that it received notice from The Nasdaq Stock Market LLC ("Nasdaq") on September 11, 2023 informing the Company that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) (the "Rule") for continued listing on the Nasdaq Capital Market.
Clever Leaves Fights Back: Bold Moves Secure Its NASDAQ Position Amid Global Cannabis Market Uncertainties
Amid challenges faced by the global cannabis market, Clever Leaves Holdings (NASDAQ:CLVR) (NASDAQ:CLVRW) has made a decisive move to maintain its listing on the U.S. stock exchange. "As a result of th
Clever Leaves to Hold Second Quarter 2023 Conference Call on Monday, August 14, 2023 at 5:00 P.m. ET
TOCANCIPÁ, Colombia, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ:CLVR, CLVRW)) ("Clever Leaves" or the "Company"), a global medicinal cannabis company, will hold a conference call on Monday,
Clever Leaves Sells Cannabis Processing Facility In Portugal To Curaleaf's Subsidiary
Clever Leaves Holdings Inc. (NASDAQ:CLVR) (NASDAQ:CLVRW) has closed the sale of the assets, including lab and processing equipment, previously used in its EU-GMP certified cannabis processing facility
Clever Leaves and Astrasana Partner to Establish International Supply Agreement For Medical Cannabis Extracts in Czech Republic and Switzerland
TOCANCIPÁ, Colombia, May 30, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) ("Clever Leaves"), a global medicinal cannabis company, announced today the arrival of the co
Clever Leaves Reminds Shareholders of Its Upcoming Annual Meeting on June 2, 2023
TOCANCIPÁ, Colombia, May 26, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ:CLVR, CLVRW)) ("Clever Leaves" or the "Company"), a global medicinal cannabis company, reminds shareholders that it will hold
Clever Leaves Partners With SOMAÍ Pharmaceuticals and Sends First Commercial Shipments to Portugal
TOCANCIPÁ, Colombia, May 25, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ:CLVR, CLVRW)), a global medicinal cannabis company, announced today that it has entered into a five-year agreement with SOMAÍ
Clever Leaves Granted Brazilian GMP Certification for Cannabis Products by ANVISA
Multinational operator has been granted Brazilian GMP certification by ANVISA for the manufacturing of cannabis productsClever Leaves is the first and only medicinal cannabis company globally who has
Clever Leaves to Present at Canaccord Genuity's 7th Annual Global Cannabis Conference
TOCANCIPÁ, Colombia, May 15, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ:CLVR, CLVRW)) ("Clever Leaves" or the "Company"), a global medicinal cannabis company, is scheduled to participate in Canaccord
Clever Leaves' Q1 Net Loss Drops Significantly After Operating Expenses Slashed By 48%
Global medicinal cannabis company Clever Leaves Holdings Inc. (NASDAQ:CLVR) (NASDAQ:CLVRW) reported late Thursday its financial and operating results for the first quarter of 2023. CEO Andres Fajardo
Clever Leaves to Hold First Quarter 2023 Conference Call on Thursday, May 11, 2023 at 5:00 P.m. ET
TOCANCIPÁ, Colombia, May 04, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) ("Clever Leaves" or the "Company"), a leading multinational operator and licensed producer of
Clever Leaves Teams Up With Hypera Pharma To Supply CBD-Dominant Oral Solutions For Brazilian Patients
Clever Leaves Holdings Inc. (NASDAQ:CLVR) (NADAQ:CLVRW) has entered into a five-year agreement with Hypera Pharma (B3:HYPE3) to supply Clever Leaves' CBD-dominant oral solutions with the aim of treati
No Data